This information is intended to provide a general overview of skull base tumours. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health.
The skull base is a complex and crucial area located behind the eyes and nose, forming the floor of the skull and acting as a wall between the brain and the face. Many essential structures, including nerves, major blood vessels, and the spinal cord, pass through the openings in the skull base.
Several different types of tumours can originate in or extend into this critical area. These tumours can be malignant (cancerous) or benign (non-cancerous). Even benign tumours can cause significant symptoms or pose a serious risk to the patient's health and well-being due to their proximity to vital structures.
At SSCHRC, our expert physicians and specialists in the Skull Base Tumour Program work collaboratively to treat patients with both cancerous and non-cancerous tumours of the skull base.
Skull base tumours are typically classified in two ways:
Based on their specific site within the head.
Based on the cell structure and identifying characteristics of the tumour itself.
The precise tumour type is determined during the patient's diagnostic workup. Radiologists and pathologists who specialise in head and brain tumours work closely with head and neck surgeons and neurosurgeons to establish a definitive tumour type. This determination, along with the patient's unique health profile, allows the skull base team to specifically tailor the treatment plan to each individual.
Skull base tumours may not cause any noticeable symptoms until they have grown to a substantial size. The specific symptoms a person experiences can vary depending on the tumour's location and how quickly it is growing.
It is important to remember that having one or more of these symptoms does not confirm a skull base tumour. If you experience any of these signs, you should consult your doctor, as they may indicate other health problems.
In some instances, skull base tumours can be inherited, meaning they are passed down from one generation to the next. Genetic counselling may be beneficial for you to understand the potential risk to yourself and your family.
Patients at SSCHRC with tumours of the skull base receive a complete diagnostic evaluation, followed by treatment and follow-up care using the latest techniques and equipment. Given the unique characteristics of each tumour type and patient, our skull base experts carefully tailor the diagnostic methods and treatment regimens to provide the most precise care.
If you have symptoms that may suggest a skull base tumour, your doctor will perform an examination and ask detailed questions about your health and symptoms. Our team of experts will then carefully select the tests best suited for your specific tumour.
Radiologists and pathologists with special expertise in head, neck, and brain tumours work alongside your doctor to determine the tumour type based on your diagnostic test results. One or more of the following tests may be used to find out if you have a skull base tumour and whether it has spread:
Imaging exams allow doctors to accurately identify the presence and location of tumours. The following may be used for skull base tumours:
During a biopsy, a small tissue sample is removed and examined under a microscope for the presence of cancer cells. Depending on the tumour's location, some biopsies can be done as an outpatient procedure with only local anaesthesia. In other cases, patients may require a surgical biopsy under general anaesthesia. Biopsy methods for skull base tumours include:
Functional testing shows how certain parts of the brain, head, and neck are working. These tests are selected based on your symptoms and the tumour's location in the skull base. They may include:
As some cases of skull base tumours can be hereditary, genetic counselling may be right for you. Learn more about the risk to you and your family on our dedicated genetic testing page.
The specialists at SSCHRC employ a comprehensive team approach to skull base tumours, bringing together exceptional expertise from neurosurgery, head and neck surgery, plastic surgery, medical oncology, radiation oncology, and many other areas. We personalise your treatment to deliver the most advanced care with the least possible impact on your body.
Skull base tumour patients benefit from advanced technology and treatments. Your recommended therapy may include:
We are also constantly engaged in research for newer, safer, and more advanced treatments for skull base tumours, allowing us to offer a range of clinical trials for new therapies.
If you are diagnosed with a skull base tumour, your doctor will discuss the best treatment options, which depend on:
Most skull base tumours require some form of surgery. Some can be treated effectively without surgery (e.g., with radiation or chemotherapy). Others may not require immediate treatment and can be closely monitored over time under the care of an experienced skull base specialist. Your treatment will always be customised to your particular needs and may include one or more of the following options.
Like all major operations, skull base tumour surgery is most successful when performed by a surgeon with extensive experience in the specific procedure.
SSCHRC's renowned skull base tumour surgeons work in multi-specialty teams. They perform numerous skull base tumour surgeries each year, utilising the most advanced techniques to select the surgical approach that is best tailored to each patient.
The main types of skull base tumour surgery include:
Radiation therapy uses powerful, focused beams of energy to kill cancer cells. There are several different radiation therapy techniques that doctors can use to accurately target a tumour while minimising damage to healthy tissue.
The types of radiation used to treat skull base tumours include:
Chemotherapy drugs are used to kill cancer cells, control their growth, or relieve disease-related symptoms. Treatment may involve a single drug or a combination of two or more drugs, depending on the type of cancer and how fast it is growing.
The immune system naturally defends the body from infection and disease. Cancer is a complex disease that can evade the immune system. Immunotherapy improves the immune system's ability to find and eliminate the cancer. Skull base tumours may be treated with immune checkpoint inhibitors, a type of immunotherapy that keeps the immune system "turned on" against the tumour.
Targeted therapy drugs are designed to stop or slow the growth or spread of cancer at a cellular level. Cancer cells need specific molecules (often proteins) to survive, multiply, and spread. Targeted therapies are designed to interfere with, or target, these cancer-promoting molecules.
Due to its status as a premier cancer centre, SSCHRC leads numerous innovative clinical trials (research studies) for skull base tumours. Studies of new treatments based on tumour cell type may include laboratory or imaging tests to monitor treatment effectiveness. Other studies track the quality of life of patients and their families, which can help lessen the effect of the tumour and its treatment on the patient's physical, mental, and social well-being.